Korean Biosimilars Giants Step Up Race To Become Innovators

Samsung Completes Bioepis Spin-Off

 
• By Jung Won Shin
  
evolution
Samsung, Celltrion Taking Different Strategies, Similar Therapeutic Focus (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business